Chemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: clues for assessing potential for cardiotoxicity.
Chemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: clues for assessing potential for cardiotoxicity.
复制标题
DOI:
10.1021/jm301204r
复制
发表时间:
2012-10-11
影响因子:
7.3
通讯作者:
Greene, Andrew S.
中科院分区:
文献类型:
--
作者:
Hoffimann, Brian R.;El-Mansy, Mohamed F.;Sem, Daniel S.;Greene, Andrew S.
Drugs typically exert desired and undesired biological effects by virtue of binding interactions with protein target(s) and off-target(s), providing evidence for drug efficacy and toxicity. Pioglitazone and rosiglitazone possess a common functional core, glitazone, which is considered a privileged scaffold upon which to build a drug selective for a given target – in this case PPARγ. Herein, we report a retrospective analysis of two variants of the glitazone scaffold, pioglitazone and rosiglitazone, in an effort to identify off-target binding events in the rat heart to explain recently reported cardiovascular risk associated with the drugs. Our results suggest glitazone has affinity for dehydrogenases, consistent with known binding preferences for related rhodanine cores. Both drugs bound ion channels and modulators, with implications in congestive heart failure, arrhythmia, and peripheral edema. Additional proteins involved in glucose homeostasis, synaptic transduction, and mitochondrial energy production were detected and potentially contribute to drug efficacy and cardiotoxicity.
登录
查看更多内容
影响因子:
3.1
作者:
Heppner, TJ;Bonev, AD;Nelson, MT
通讯作者:
Nelson, MT
影响因子:
2.9
作者:
Gutschi, L. Maria;Malcolm, Janine C.;Ooi, Teik Chye
通讯作者:
Ooi, Teik Chye
影响因子:
5
作者:
Knock, GA;Mishra, SK;Aaronson, PI
通讯作者:
Aaronson, PI
影响因子:
4.8
作者:
Dello Russo, C;Gavrilyuk, V;Feinstein, DL
通讯作者:
Feinstein, DL
影响因子:
3.4
作者:
Halligan, Brian D.;Greene, Andrew S.
通讯作者:
Greene, Andrew S.